Lifesaving Catheters are Endangering Patients’ Lives

By :  IDN
Update: 2024-11-25 15:25 GMT

A shocking case of corruption has emerged at Kolkata Medical College, where lifesaving medical devices meant to save lives are allegedly putting patients at risk.

The controversy centers around Central Venous Catheters (CVCs)—critical medical devices used in complex surgeries to administer medication through the neck or groin. These catheters are vital for patient care, yet recent reports reveal that substandard products are being supplied in place of the high-quality devices mandated by tenders.

According to sources, a multinational company, Vygon, was awarded the tender to supply premium-quality catheters to hospitals across the state. However, its local distributor has allegedly been supplying low-grade, locally manufactured catheters instead. This malpractice has reportedly affected several prominent hospitals, including SSKM, MR Bangur Hospital, and Bankura Medical College.

Serious Allegations Against the Supply Chain

Insiders in the health department suggest significant irregularities in the procurement process. Protocol dictates that orders should be placed directly with the multinational company, which then ensures supply through its authorized distributor. Yet, questions arise as to how these substandard products infiltrated the supply chain.

This also raises serious concerns about the role of Vygon’s local management, based in Gurugram near Delhi, and their oversight and possible complicity in malafide distribution operations. _The company’s Indian subsidiary has three directors of French origin and only one of Indian origin who is also their Managing Director._

Troubling Patterns Emerge

Trying to attempt seeming cover ups the Managing Director has reportedly issued gag orders to its employees. 

The Bigger Picture

These allegations suggest deeper issues within the multinational company’s local and global management and needs a thorough scan. If proven, this malpractice not only undermines public trust but also endangers lives, highlighting the need for stringent regulatory oversight in the medical device industry.

Tags:    

Similar News